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in the spinal cord/cauda equina. For pilocytic tumors located in the cerebel-
lum, 10-year relative survival was similar for the 0–4 year (100%), 5–9 year 
(100%), 10–14 year (96.4%), and 15–19 year (98.2%) age groups, while 
survival was significantly lower for the >20 age group (84.3%). Ten-year 
relative survival estimates did not significantly differ between males and 
females either overall or by site or age group. Overall, 10-year survival for 
pilocytic astrocytomas on a population-based level is quite good; however, 
long-term survival data and quality of life measurements will be necessary 
to more accurately define the clinical aspects of the disease.
EPI 10. DIFFERENCES IN THE DISTRIBUTION OF BRAIN 
TUMORS BY PRIMARY SITE IN CHILDREN, YOUNG 
ADULTS, AND ADULTS
Bridget Mccarthy1 and Jennifer Propp1; 1University of Illinois at Chicago, 
Chicago, IL, USA.
Pediatric brain tumors are known to differ from adult brain tumors 
in terms of most common histologies. In addition, pediatric brain tumors 
occur in specific brain sites with different frequencies than adult brain 
tumors. In an effort to document the primary site differences among chil-
dren (0–14 years), young adults (15–29 years), and adults (>30 years) in 
a population-based manner, data on all primary brain tumors from the 
Central Brain Tumor Registry of the United States for the years 2000–2004 
were analyzed. Of 74,825 primary brain tumors, 4,551 tumors (3,510 
malignant and 1,041 nonmalignant) were found in children, 5,124 tumors 
(2,547 malignant and 2,577 nonmalignant) were found in young adults, 
and 65,150 tumors (27,283 malignant and 37,867 nonmalignant) were 
found in adults. A difference of greater than 5% in the frequency of all 
tumors by primary site was found for the meninges (0–14: 1.5%; 15–29: 
8.7%; >30: 29.4%), the frontal lobe (0–14: 5.4%; 15–29: 12.1%; >30: 
11.6%), the cerebellum (0–14: 18.4%; 15–29: 7.4%; >30: 2.2%), the brain-
stem (0–14: 14.1%; 15–29: 3.9%; >30: 1.0%), brain NOS (0–14: 14.6%; 
15–29: 7.2%; >30: 8.1%), and the pituitary (0–14: 2.0%; 15–29: 18.4%; 
>30: 8.6%). For malignant tumors, adults had a higher frequency of tumors 
in the frontal, temporal, and parietal lobes and overlapping brain sites and 
a lower frequency of tumors in the cerebellum and brainstem than chil-
dren. Adults had a higher frequency of tumors of the temporal and parietal 
lobes than young adults. Young adults had a higher frequency of tumors 
of the temporal lobe and a lower frequency of tumors in the cerebellum 
and brainstem than children. For nonmalignant tumors, both adults and 
young adults had higher frequencies of tumors in the meninges and pituitary 
and acoustic nerve tumors but lower frequencies of tumors in the temporal 
lobe, ventricles, brain NOS, and craniopharyngeal duct than children. The 
highest frequency of tumors in the pituitary was found in young adults com-
pared to either adults or children. By histology, the astrocytic tumors were 
more frequent in children in the cerebrum and brainstem than in adults, but 
more frequent in the lobes in adults compared to children. Ependymomas 
were more frequent in the brainstem and brain NOS in children compared 
to adults, but there was a higher frequency of these tumors in the spinal 
cord in young adults and adults compared to children. While tumors of 
the meninges were most frequently reported in the cerebral meninges in all 
three age groups, children had a greater frequency of these tumors reported 
in the spinal meninges than adults or young adults. Further differences in 
brain tumor frequency by primary site will be presented.
EPI 11. EPIDEMIOLOGY AND TREATMENT OUTCOME  
OF CHILDHOOD EPENDYMOMA: REPORT FROM THE 
HONG KONG PEDIATRIC HEMATOLOGY ONCOLOGY 
STUDY GROUP
Chi Fung Godfrey Chan,1 Matthew Ming-Kong Shing,2 Hui-Leung 
Yuen,3 Anselm Chi-Wai Lee,4 Chi-Keung Li,5 Chung-Wing Luk,3  
Shau-Yin Ha,1 and Chi-Kong Li2; 1Paediatrics and Adolescent Medicine, 
University of Hong Kong, Hong Kong, China; 2Paediatrics and 
Adolescent Medicine, Chinese University of Hong Kong, Hong Kong, 
China; 3Paediatrics and Adolescent Medicine, Queen Elizabeth Hospital, 
Hong Kong, China; 4Paediatrics and Adolescent Medicine, Tuen Mun 
Hospital, Hong Kong, China; 5Paediatrics and Adolescent Medicine, 
Princess Margaret Hospital, Hong Kong, China.
Objective: Ependymoma is the fourth commonest childhood brain 
tumor, but there was little information on its epidemiology and outcome 
in Chinese children. We reviewed our data and provide some insight in 
this aspect.
Materials and Methods: Prospective collection of childhood cancer 
data was performed since early 1990s from the five major public hospi-
tals, which captured almost all children with cancers locally. Standard data 
accrual was performed by designated data managers. The data was further 
crosschecked with the Hong Kong Cancer Registry database, which col-
lected all the local pathology reports for cancers. Chemotherapy regimen 
was baby-POG before 2005 and SIOP-99 after 2004.
Results: From January 1995 to December 2006 (12 years), a total of 
20 cases of childhood (<18 years) ependymoma were diagnosed. Their 
median age was 3.4 years (range, 0.5–16.3 years), and male:female ratio 
was 8:12. Excluding one non-Chinese and one .15 years, the incidence 
of ependymoma was 1.3/1,000,000 per year for children <15 years. The 
distribution was fairly even between the cerebral (n 5 9) and posterior fossa 
(n 5 9), and two were in the spinal cord region. Chemotherapy was given to 
10 children, mostly for children ,3 years in order to delay cranial radiation 
therapy (RT) (n 5 6) or for children with incomplete surgical excision (n 5 
4). The 5-year overall survival rate was 69% but was 87.5% for cerebral and 
53.3% for posterior fossa location (p 5 0.14), mainly because seven of nine 
(77%) children with posterior fossa ependymoma were ,3 years (median 
age, 1.5 years; range, 0.5–5.1 years) and RT was postponed. On the con-
trary, only two of nine children with cerebral ependymomas were ,3 years 
(median, 5.8 years; range, 2.3–16.3 years). Eight of 10 patients with either 
cerebral or posterior fossa ependymoma who did not receive upfront cranial 
RT (,3 years or parents refused) relapsed, irrespective of the completeness 
of the initial surgical resection or chemotherapy used. The two patients with 
spinal ependymoma were treated with surgery alone, and one relapsed; he 
was successfully re-treated with surgery plus local RT.
Conclusion: Ependymoma is less common among Chinese children, 
and the majority of our children with posterior fossa ependymoma were 
,3 years. Without upfront cranial RT, 80% of our cerebral or cerebellar 
ependymomas relapsed. The data managers were supported by the Chil-
dren’s Cancer Foundation of Hong Kong.
EPI 12. EPIDEMIOLOGY OF PEDIATRIC CNS GERM CELL 
TUMORS: A CALIFORNIA CANCER REGISTRY STUDY
Sonia Partap,1 Julie Von Behren,2 Jane Maclean,1 Paul Fisher,1 and 
Peggy Reynolds2; 1Stanford University, Palo Alto, CA, USA; 2Northern 
California Cancer Center, Berkeley, CA, USA.
Background: Pediatric CNS germ cell tumors (GCTs) are reported to 
comprise 2%–4% of childhood brain tumors, with an even greater preva-
lence in Asians. In the United States GCTs have historically been separated 
from other brain tumors when sorted by the International Classification of 
Childhood Cancer and thus are often neglected in analyses. Past Western 
studies of GCTs have also been limited by small sample sizes.
Methods: We aimed to perform a rigorous, descriptive analysis of child-
hood CNS GCTs, using data from the population-based California Cancer 
Registry.
Results: We obtained data on 4,070 CNS cancers, diagnosed from 1988 
through 2004 in children ages 0–14 years; 214 (5.3% of sample) primary 
intracranial and intraspinal germ cell tumors were identified. Mean age at 
diagnosis was 9.1 years, and 68% of tumors occurred in males. The most 
common tumor location was the pineal gland (93 cases, 43%) with 7.5% of 
cases in the sellar region. Of the cases, 43% were Hispanic children, 35% 
white, 16% Asian, and 6% African American, compared to general Cali-
fornia childhood population ethnic frequencies of approximately 42% His-
panic, 37% white, 10% Asian, and 7% African American. Histologically, 
131 cases (61%) were reported as germinomas, with the remainder distrib-
uted among various pathologic classifications. The overall frequency of 
CNS GCTs in our cohort was 5.3%, with 11% of cases occurring between 
ages 0 and 1 year and 62% between ages 10 and 14 years. Children ,1 year 
most often had malignant teratomas, with more females than males (16 vs. 
7, p < 0.001, chi-square test). GCT incidence increased starting at age 7 and 
continued to rise at age 14. The proportion seen in males was greater than 
twofold that in females (p , 0.05).
Conclusion: With the largest pediatric intracranial and intraspinal 
germ cell tumor series in the United States to date, our study reveals that 
CNS GCTs may be more prevalent among Western pediatric brain tumors 
than initially reported. Overall these tumors were more common among 
males; however, female infants were affected more than males, a differ-
ence that has not been previously reported. While our sample might be 
influenced by a high proportion of Asian Americans, the patterns observed 
differ from Asian series.
